Valuation: Integra LifeSciences Holdings Corporation

Market Cap 1.25B 1.09B 1.02B 934M 1.75B 119B 1.75B 12.28B 4.74B 60.82B 4.68B 4.58B 196B P/E 2026 *
25x
P/E 2027 * 12.9x
Enterprise Value 2.74B 2.39B 2.25B 2.05B 3.85B 261B 3.85B 26.96B 10.4B 134B 10.27B 10.05B 430B EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.46x
Free-Float
72.35%
Yield 2026 *
-
Yield 2027 * -
1 day+2.76%
1 week+2.10%
Current month-5.32%
1 month-4.30%
3 months-8.98%
6 months+79.19%
Current year+28.99%
1 week 14.88
Extreme 14.875
16.38
1 month 14.88
Extreme 14.875
17.33
Current year 8.7
Extreme 8.7
20.49
1 year 8.7
Extreme 8.7
20.49
3 years 8.7
Extreme 8.7
45.42
5 years 8.7
Extreme 8.7
74.98
10 years 8.7
Extreme 8.7
77.4
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2026
Director of Finance/CFO 54 28/06/2023
Chief Tech/Sci/R&D Officer - 17/02/2026
Director TitleAgeSince
Chairman 64 03/01/2012
Director/Board Member 81 01/01/1992
Director/Board Member 65 01/01/2006
Date Insider Type Main position Quantity % Market Cap. Importance
1/9/26 Tax

Head of Human Resources

-1,455 0.0019%
3/7/26 Tax

Chief Financial Officer

-5,226 0.0067%
1/7/26 Free

Executive/Senior Manager

5,590 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
+2.76%+2.10%+11.17%-58.45% 1.25B
+0.69%+1.63%-24.10%+5.64% 179B
-1.07%-3.18%-4.07%+13.08% 116B
-0.65%-2.74%+8.88%+69.09% 60B
+1.27%-1.57%-1.90%-31.00% 49.85B
-0.22%+1.23%+7.80%+45.79% 48.05B
+0.40%+3.56%+28.80%+2.32% 33.79B
+7.73%+7.23% - - 30.21B
+2.57%+1.67%+47.13%-0.38% 26.12B
+2.38%+8.63%+11.66%-10.18% 22.98B
Average +1.59%+1.71%+9.48%+3.99% 56.78B
Weighted average by Cap. +0.68%+0.44%-2.79%+13.20%

Financials

2026 *2027 *
Net sales 1.67B 1.46B 1.38B 1.26B 2.36B 160B 2.36B 16.51B 6.37B 81.75B 6.29B 6.15B 264B 1.73B 1.51B 1.42B 1.29B 2.43B 165B 2.43B 17.03B 6.57B 84.34B 6.49B 6.35B 272B
Net income 42.03M 36.73M 34.52M 31.5M 59.13M 4.02B 59.14M 414M 160M 2.05B 158M 154M 6.62B 78.69M 68.77M 64.63M 58.98M 111M 7.52B 111M 776M 299M 3.84B 296M 289M 12.39B
Net Debt 1.49B 1.3B 1.22B 1.12B 2.1B 142B 2.1B 14.68B 5.67B 72.71B 5.59B 5.47B 234B 1.28B 1.12B 1.06B 963M 1.81B 123B 1.81B 12.67B 4.89B 62.73B 4.83B 4.72B 202B
Logo Integra LifeSciences Holdings Corporation
Integra LifeSciences Holdings Corporation is a global medical technology company. It manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). CSS consists of technologies and instrumentations used for specialties, such as neurosurgery, neurocritical care, and otolaryngology. CSS neurosurgical business includes a portfolio of brands, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. It provides instruments that are used in precision, specialty and general surgical procedures. TT includes Wound Reconstruction and Care business, which sells offerings, such as skin and wound repair, plastics and surgical reconstruction products and nerve and tendon repair products. Its products include CUSA Platform, Codman Neurosurgical Accessories, DuraGen Dural Graft Matrix, DuraSeal Dural Sealant System and others.
Employees
4,427
Date Price Change Volume
22/09/26 USD 16.02 +2.76% 770,454
21/09/26 USD 15.59 +2.43% 1,064,157
18/09/26 USD 15.22 +0.79% 2,169,063
17/09/26 USD 15.10 -5.98% 1,051,358
16/09/26 USD 16.06 +2.36% 1,618,120
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
16.02USD
Average target price
19.56USD
Spread / Average Target
+22.07%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IART Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!